211 related articles for article (PubMed ID: 2891432)
1. Acromegaly from ectopic growth hormone-releasing hormone secretion by a malignant carcinoid tumor. Successful treatment with long-acting somatostatin analogue SMS 201-995.
Barkan AL; Shenker Y; Grekin RJ; Vale WW
Cancer; 1988 Jan; 61(2):221-6. PubMed ID: 2891432
[TBL] [Abstract][Full Text] [Related]
2. Treatment of acromegaly with the long-acting somatostatin analog SMS 201-995.
Barkan AL; Kelch RP; Hopwood NJ; Beitins IZ
J Clin Endocrinol Metab; 1988 Jan; 66(1):16-23. PubMed ID: 2891720
[TBL] [Abstract][Full Text] [Related]
3. Medical management of acromegaly due to ectopic production of growth hormone-releasing hormone by a carcinoid tumor.
Melmed S; Ziel FH; Braunstein GD; Downs T; Frohman LA
J Clin Endocrinol Metab; 1988 Aug; 67(2):395-9. PubMed ID: 2899089
[TBL] [Abstract][Full Text] [Related]
4. Acromegaly due to ectopic growth hormone-releasing hormone secretion by a bronchial carcinoid tumour. Dynamic hormonal responses to various stimuli.
Glikson M; Gil-Ad I; Galun E; Dresner R; Zilberman S; Halperin Y; Okon E; Laron Z; Rubinow A
Acta Endocrinol (Copenh); 1991 Oct; 125(4):366-71. PubMed ID: 1683501
[TBL] [Abstract][Full Text] [Related]
5. Ectopic growth hormone-releasing hormone secretion by a metastatic bronchial carcinoid tumor: a case with a non hypophysial intracranial tumor that shrank during long acting octreotide treatment.
Fainstein Day P; Frohman L; Garcia Rivello H; Reubi JC; Sevlever G; Glerean M; Fernandez Gianotti T; Pietrani M; Rabadan A; Racioppi S; Bidlingmaier M
Pituitary; 2007; 10(3):311-9. PubMed ID: 17373589
[TBL] [Abstract][Full Text] [Related]
6. Reduction of pituitary size by the somatostatin analogue SMS 201-995 in a patient with an islet cell tumour secreting growth hormone releasing factor.
Wilson DM; Hoffman AR
Acta Endocrinol (Copenh); 1986 Sep; 113(1):23-8. PubMed ID: 2876570
[TBL] [Abstract][Full Text] [Related]
7. Long-term treatment of acromegaly with Sandostatin (SMS 201-995). Normalization of most anomalous growth hormone responses.
Pieters GF; van Liessum PA; Smals AG; van Gennep JA; Benraad TJ; Kloppenborg PW
Acta Endocrinol Suppl (Copenh); 1987; 286():9-18. PubMed ID: 2892339
[TBL] [Abstract][Full Text] [Related]
8. Long-acting lanreotide induces clinical and biochemical remission of acromegaly caused by disseminated growth hormone-releasing hormone-secreting carcinoid.
Drange MR; Melmed S
J Clin Endocrinol Metab; 1998 Sep; 83(9):3104-9. PubMed ID: 9745411
[TBL] [Abstract][Full Text] [Related]
9. Acromegaly due to ectopic growth hormone (GH)-releasing hormone (GHRH) production: dynamic studies of GH and ectopic GHRH secretion.
Barkan AL; Shenker Y; Grekin RJ; Vale WW; Lloyd RV; Beals TF
J Clin Endocrinol Metab; 1986 Nov; 63(5):1057-64. PubMed ID: 3093517
[TBL] [Abstract][Full Text] [Related]
10. Neuroendocrine tumors secreting growth hormone-releasing hormone: Pathophysiological and clinical aspects.
Gola M; Doga M; Bonadonna S; Mazziotti G; Vescovi PP; Giustina A
Pituitary; 2006; 9(3):221-9. PubMed ID: 17036195
[TBL] [Abstract][Full Text] [Related]
11. Ectopic growth hormone-releasing hormone (GHRH) syndrome in a case with multiple endocrine neoplasia type I.
Yamasaki R; Saito H; Sano T; Kameyama K; Yoshimoto K; Hosoi E; Matsumura M; Harada K; Saito S
Endocrinol Jpn; 1988 Feb; 35(1):97-109. PubMed ID: 2899505
[TBL] [Abstract][Full Text] [Related]
12. Medical treatment of acromegaly with SMS 201-995, a somatostatin analog: a comparison with bromocriptine.
Chiodini PG; Cozzi R; Dallabonzana D; Oppizzi G; Verde G; Petroncini M; Liuzzi A; del Pozo E
J Clin Endocrinol Metab; 1987 Mar; 64(3):447-53. PubMed ID: 2880861
[TBL] [Abstract][Full Text] [Related]
13. NIH conference. Somatostatin and somatostatin analogue (SMS 201-995) in treatment of hormone-secreting tumors of the pituitary and gastrointestinal tract and non-neoplastic diseases of the gut.
Gorden P; Comi RJ; Maton PN; Go VL
Ann Intern Med; 1989 Jan; 110(1):35-50. PubMed ID: 2535688
[TBL] [Abstract][Full Text] [Related]
14. Somatostatin analog treatment of acromegaly: new aspects.
Lamberts SW; del Pozo E
Horm Res; 1988; 29(2-3):115-7. PubMed ID: 2900190
[TBL] [Abstract][Full Text] [Related]
15. Long-term treatment of acromegaly with the somatostatin analogue SMS 201-995.
Lamberts SW; Uitterlinden P; Verschoor L; van Dongen KJ; del Pozo E
N Engl J Med; 1985 Dec; 313(25):1576-80. PubMed ID: 2866445
[TBL] [Abstract][Full Text] [Related]
16. Subcutaneous octreotide treatment of a growth hormone-releasing hormone-secreting bronchial carcinoid: superiority of continuous versus intermittent administration to control hormonal secretion.
Lefebvre S; De Paepe L; Abs R; Rahier J; Selvais P; Maiter D
Eur J Endocrinol; 1995 Sep; 133(3):320-4. PubMed ID: 7581949
[TBL] [Abstract][Full Text] [Related]
17. Acromegaly.
Bloom SR
Am J Med; 1987 May; 82(5B):88-91. PubMed ID: 2884882
[TBL] [Abstract][Full Text] [Related]
18. A comparison among the effectiveness of growth hormone suppression in active acromegaly of bromocriptine and long acting somatostatin analogue (SMS 201-995).
Popović V; Nesović M; Mićić D; Kendereski A; Djordjević P; Manojlović D; Mićić J
Exp Clin Endocrinol; 1990 Apr; 95(2):251-7. PubMed ID: 1973122
[TBL] [Abstract][Full Text] [Related]
19. Studies on the response of growth hormone (GH) secretion to GH-releasing hormone, thyrotropin-releasing hormone, gonadotropin-releasing hormone, and somatostatin in acromegaly.
Shibasaki T; Hotta M; Masuda A; Imaki T; Obara N; Hizuka N; Takano K; Wakabayashi I; Demura H; Ling N
J Clin Endocrinol Metab; 1986 Jul; 63(1):167-73. PubMed ID: 2872226
[TBL] [Abstract][Full Text] [Related]
20. Recurrent acromegaly resulting from ectopic growth hormone gene expression by a metastatic pancreatic tumor.
Ezzat S; Ezrin C; Yamashita S; Melmed S
Cancer; 1993 Jan; 71(1):66-70. PubMed ID: 8416728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]